These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 21406034

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications.
    Musilek K, Komloova M, Zavadova V, Holas O, Hrabinova M, Pohanka M, Dohnal V, Nachon F, Dolezal M, Kuca K, Jung YS.
    Bioorg Med Chem Lett; 2010 Mar 01; 20(5):1763-6. PubMed ID: 20138518
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Preparation, in vitro screening and molecular modelling of symmetrical 4-tert-butylpyridinium cholinesterase inhibitors--analogues of SAD-128.
    Musilek K, Roder J, Komloova M, Holas O, Hrabinova M, Pohanka M, Dohnal V, Opletalova V, Kuca K, Jung YS.
    Bioorg Med Chem Lett; 2011 Jan 01; 21(1):150-4. PubMed ID: 21144749
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors--implications for early myasthenia gravis treatment.
    Komloova M, Musilek K, Horova A, Holas O, Dohnal V, Gunn-Moore F, Kuca K.
    Bioorg Med Chem Lett; 2011 Apr 15; 21(8):2505-9. PubMed ID: 21397501
    [Abstract] [Full Text] [Related]

  • 7. Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors.
    Carolan CG, Dillon GP, Gaynor JM, Reidy S, Ryder SA, Khan D, Marquez JF, Gilmer JF.
    J Med Chem; 2008 Oct 23; 51(20):6400-9. PubMed ID: 18817366
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and insecticidal activity of novel carbamate derivatives as potential dual-binding site acetylcholinesterase inhibitors.
    Ma HJ, Xie RL, Zhao QF, Mei XD, Ning J.
    J Agric Food Chem; 2010 Dec 22; 58(24):12817-21. PubMed ID: 21114293
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and biological evaluation of 1,3,4-thiadiazole analogues as novel AChE and BuChE inhibitors.
    Skrzypek A, Matysiak J, Niewiadomy A, Bajda M, Szymański P.
    Eur J Med Chem; 2013 Apr 22; 62():311-9. PubMed ID: 23376249
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.
    Korabecny J, Musilek K, Holas O, Binder J, Zemek F, Marek J, Pohanka M, Opletalova V, Dohnal V, Kuca K.
    Bioorg Med Chem Lett; 2010 Oct 15; 20(20):6093-5. PubMed ID: 20817518
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
    Sheng R, Lin X, Zhang J, Chol KS, Huang W, Yang B, He Q, Hu Y.
    Bioorg Med Chem; 2009 Sep 15; 17(18):6692-8. PubMed ID: 19692250
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and acetylcholinesterase and butyrylcholinesterase inhibitory activities of 7-alkoxyl substituted indolizinoquinoline-5,12-dione derivatives.
    Wu ZP, Wu XW, Shen T, Li YP, Cheng X, Gu LQ, Huang ZS, An LK.
    Arch Pharm (Weinheim); 2012 Mar 15; 345(3):175-84. PubMed ID: 21989769
    [Abstract] [Full Text] [Related]

  • 13. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
    Belluti F, Rampa A, Piazzi L, Bisi A, Gobbi S, Bartolini M, Andrisano V, Cavalli A, Recanatini M, Valenti P.
    J Med Chem; 2005 Jun 30; 48(13):4444-56. PubMed ID: 15974596
    [Abstract] [Full Text] [Related]

  • 14. Preparation, in vitro evaluation and molecular modelling of pyridinium-quinolinium/isoquinolinium non-symmetrical bisquaternary cholinesterase inhibitors.
    Komloova M, Horova A, Hrabinova M, Jun D, Dolezal M, Vinsova J, Kuca K, Musilek K.
    Bioorg Med Chem Lett; 2013 Dec 15; 23(24):6663-6. PubMed ID: 24220173
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE, Park JY, No KT, Shin JH, Lee SK, Eun JS, Yang JH, Shin TY, Kim DK, Chae BS, Leem JY, Kim KH.
    Bioorg Med Chem; 2007 Oct 15; 15(20):6596-607. PubMed ID: 17681794
    [Abstract] [Full Text] [Related]

  • 16. Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation.
    Xie Q, Wang H, Xia Z, Lu M, Zhang W, Wang X, Fu W, Tang Y, Sheng W, Li W, Zhou W, Zhu X, Qiu Z, Chen H.
    J Med Chem; 2008 Apr 10; 51(7):2027-36. PubMed ID: 18333606
    [Abstract] [Full Text] [Related]

  • 17. Structure-activity relationships and binding mode in the human acetylcholinesterase active site of pseudo-irreversible inhibitors related to xanthostigmine.
    Rizzo S, Cavalli A, Ceccarini L, Bartolini M, Belluti F, Bisi A, Andrisano V, Recanatini M, Rampa A.
    ChemMedChem; 2009 Apr 10; 4(4):670-9. PubMed ID: 19222043
    [Abstract] [Full Text] [Related]

  • 18. New potent human acetylcholinesterase inhibitors in the tetracyclic triterpene series with inhibitory potency on amyloid β aggregation.
    Rouleau J, Iorga BI, Guillou C.
    Eur J Med Chem; 2011 Jun 10; 46(6):2193-205. PubMed ID: 21435752
    [Abstract] [Full Text] [Related]

  • 19. Cholinesterase inhibitory activities of some flavonoid derivatives and chosen xanthone and their molecular docking studies.
    Khan MT, Orhan I, Senol FS, Kartal M, Sener B, Dvorská M, Smejkal K, Slapetová T.
    Chem Biol Interact; 2009 Oct 30; 181(3):383-9. PubMed ID: 19596285
    [Abstract] [Full Text] [Related]

  • 20. Identical kinetics of human erythrocyte and muscle acetylcholinesterase with respect to carbamate pre-treatment, residual activity upon soman challenge and spontaneous reactivation after withdrawal of the inhibitors.
    Herkert NM, Eckert S, Eyer P, Bumm R, Weber G, Thiermann H, Worek F.
    Toxicology; 2008 Apr 18; 246(2-3):188-92. PubMed ID: 18304715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.